Vanderbilt Team Tracks Cellular and Antibody Responses to COVID-19 Vaccine
July 21, 2022
July 21, 2022
NASHVILLE, Tennessee, July 21 (TNSjou) -- Vanderbilt University Medical Center issued the following news:
In a technical tour de force, a collaborative team of Vanderbilt researchers has characterized the antigen-specific immune response to the Pfizer SARS-CoV-2 RNA vaccine.
The group used multiple single-cell technologies, unbiased machine learning, and traditional immunological approaches to track cellular and antibody responses in samples collected over time from a c . . .
In a technical tour de force, a collaborative team of Vanderbilt researchers has characterized the antigen-specific immune response to the Pfizer SARS-CoV-2 RNA vaccine.
The group used multiple single-cell technologies, unbiased machine learning, and traditional immunological approaches to track cellular and antibody responses in samples collected over time from a c . . .